Innate defenses to virus infections are triggered by pattern recognition receptors (PRRs). The two cytoplasmic PRRs RIG-I and PKR bind to viral signature RNAs, change conformation, oligomerize, and activate antiviral signaling. Methods are described which allow to conveniently monitor the conformational switching and the oligomerization of these cytoplasmic PRRs.
Host defenses to virus infection are dependent on a rapid detection by pattern recognition receptors (PRRs) of the innate immune system. In the cytoplasm, the PRRs RIG-I and PKR bind to specific viral RNA ligands. This first mediates conformational switching and oligomerization, and then enables activation of an antiviral interferon response. While methods to measure antiviral host gene expression are well established, methods to directly monitor the activation states of RIG-I and PKR are only partially and less well established.
Here, we describe two methods to monitor RIG-I and PKR stimulation upon infection with an established interferon inducer, the Rift Valley fever virus mutant clone 13 (Cl 13). Limited trypsin digestion allows to analyze alterations in protease sensitivity, indicating conformational changes of the PRRs. Trypsin digestion of lysates from mock infected cells results in a rapid degradation of RIG-I and PKR, whereas Cl 13 infection leads to the emergence of a protease-resistant RIG-I fragment. Also PKR shows a virus-induced partial resistance to trypsin digestion, which coincides with its hallmark phosphorylation at Thr 446. The formation of RIG-I and PKR oligomers was validated by native polyacrylamide gel electrophoresis (PAGE). Upon infection, there is a strong accumulation of RIG-I and PKR oligomeric complexes, whereas these proteins remained as monomers in mock infected samples.
Limited protease digestion and native PAGE, both coupled to western blot analysis, allow a sensitive and direct measurement of two diverse steps of RIG-I and PKR activation. These techniques are relatively easy and quick to perform and do not require expensive equipment.
A crucial event in antiviral host defense is the rapid detection of the pathogen by the so-called pattern recognition receptors (PRRs)1,2. Intracellular detection of RNA virus infection is dependent on two cytoplasmic RNA helicases, RIG-I (retinoic acid inducible gene I) and MDA5 (melanoma differentiation associated protein 5)3-5. RIG-I is composed of two N-terminal caspase recruitment domains (CARDs), a central DECH-box type RNA helicase domain, and a C-terminal domain (CTD)4,6. Whereas the CTD and the helicase domain are required for recognition of non-self (viral) RNAs, the CARDs mediate downstream signaling leading to establishment of an antiviral host status.
If RIG-I is in the silent state, i.e. in the absence of a specific RNA ligand, the second CARD interacts with the central helicase domain and keeps RIG-I in an auto-inhibitory conformation7-11. RIG-I binds to short double-strand (ds) RNA bearing a 5’-triphosphate (5’PPP), long dsRNA, and polyU/UC-rich RNA, classic signature structures which are present on the genomes of many RNA viruses12-16. Two major characteristics of RIG-I activation are a switch to a closed conformation6,17 and the homo-oligomerization6,18,19. The conformational switch enhances RNA binding, exposes the CARDs for downstream signaling, and reconstitutes an active ATPase site8,9,11,20. The formation of oligomeric RIG-I complexes leads to enhanced recruitment of downstream signaling adaptor molecules to form a platform for antiviral signal transduction11. The RIG-I-regulated signaling chain eventually activates the transcription factor IRF-3 for up-regulation of interferon (IFN-alpha/beta) genes and hence the gene expression of interferon stimulated genes (ISGs) for a full antiviral response21,22. One of the best characterized ISGs is the RNA-activated protein kinase (PKR) 23. PKR belongs to the family of eukaryotic translation initiation factor 2 alpha (eIF2α) kinases and is composed of an N-terminal double-stranded RNA binding domain and a C-terminal kinase domain. The kinase domain constitutes the dimerization interface crucial for PKR activation and carries out the catalytic functions of the protein. Binding of PKR to viral dsRNA leads to its conformational change permitting dimerization and auto-phosphorylation at Thr 446 among other residues. PKR then mediates phosphorylation of eIF2α, thereby blocking the translation of viral mRNAs23-27.
Both RIG-I and PKR undergo major structural rearrangements, form oligomeric complexes and are post-translationally modified by phosphorylation/dephosphorylation and ubiquitination10,11,19,23,24,26-29. For a better understanding of which viral RNA structures are activating RIG-I and PKR (and at what stage viral antagonists could be interfering), it is important to precisely determine the activation status. For both PRRs it was previously described that activation leads to the emergence of trypsin-resistant protein fragments6,17,30 and higher-order oligomers6,18,19. However, given the wealth of literature on these key factors of the antiviral host response1,2,24, application of direct methods seems comparatively rare. In the hope of stimulating broader usage, we provide convenient and sensitive protocols to robustly analyze the activation states of RIG-I and PKR. The IFN competent human cell line A549 is infected with an established activator of RIG-I and PKR, the attenuated Rift Valley fever virus mutant clone 13 (Cl 13)31,32. After a simple lysing procedure, the extracts of infected cells are tested by limited trypsin digestion/western blot analysis to evaluate conformational switching, and by blue native polyacrylamide gel electrophoresis (PAGE) /Western blot analysis to measure formation of oligomers.
1. Seeding of A549 Cells for Infection
2. Infection with Rift Valley Fever Virus Clone 13 (Cl 13)
3. Preparation of Cell Lysates
4. Determination of Conformational Changes of Pattern Recognition Receptors
5. Analysis of Oligomeric States of Pattern Recognition Receptors
Recognition of a viral agonist by RIG-I or PKR triggers conformational switching6,17,30 and oligomerization6,18,27. We assayed these two activation markers by limited protease digestion and native polyacrylamide gel electrophoresis (PAGE), respectively.
Human A549 cells were infected with Rift Valley fever virus clone 13 (Cl 13), which is characterized by a mutation of the IFN antagonist NSs35,36. Due to the absence of functional NSs, Clone 13 strongly induces RIG-I and PKR, leading to the establishment of a robust antiviral state in the cells12,31,32,37.
Trypsin digestion of mock infected cell lysates results in a rapid degradation of RIG-I, whereas Cl 13 infection leads to the generation of a 30 kDa resistant RIG-I fragment Figure 1A. Also PKR shows partial resistance to trypsin digestion in infected samples, which coincides with its phosphorylation Figure 1A. To monitor efficiency and specificity of trypsin digestion, gels were stained with Coomassie Brilliant Blue G-250. Untreated samples show equal amounts of loaded proteins Figure 1B. Subjecting mock and Cl 13 cell lysates to trypsin digestion leads to a comparable decrease of global protein amounts. This demonstrates that trypsin treatment has the same efficiency for mock and Cl 13-infected samples.
The formation of oligomeric complexes was assayed by native PAGE. In uninfected cells, only monomers of RIG-I and PKR were detected Figure 2. As additional control we included the transcription factor IRF-3, which is present as a monomer but known to dimerize upon activation via e.g., RIG-I38. Cl 13 infection leads to a strong accumulation of RIG-I oligomeric complexes in form of a smear and of PKR and IRF-3 dimers/oligomers as a defined protein band.
These results demonstrate that limited trypsin digestion and native PAGE are useful tools to monitor conformational changes and oligomer formation of RIG-I and PKR upon infection.
Figure 1. Conformational switch of RIG-I and PKR. A549 cells were mock infected or infected with Cl 13 at an MOI of 5. After 5 hr, cells were lysed in PBS supplemented with 0.5% Triton X-100 and cleared cell lysates were either left untreated or treated with trypsin. Samples were subjected to SDS PAGE followed by Western blotting (A) or Coomassie staining (B). Blots were stained against RIG-I, PKR, phosphorylated PKR (Thr 446) and against RVFV nucleoprotein (RVFV N) and beta-actin as infection and loading control, respectively. Please click here to view a larger version of this figure.
Figure 2. Oligomerization of RIG-I, PKR, and IRF-3. Cell lysates of mock and Cl 13-infected cell lysates were subjected to native PAGE followed by Western blot analysis. Staining was performed with antibodies against RIG-I, PKR, IRF-3, and beta-actin as loading control. PKR oligomers most likely represent dimers27. Please click here to view a larger version of this figure.
Sensing the presence of viruses and activation of the antiviral type I IFN system are crucial for successful innate immune responses22. Virus detection is thereby mediated by pathogen recognition receptors (PRRs) like RIG-I and PKR, enabling a rapid response and activation of antiviral defense mechanisms. Here, we describe two methods to directly evaluate the activation status of RIG-I and PKR.
Limited protease digestion as a tool to monitor conformational changes of RIG-I and PKR was first described by the groups of M. Gale Jr. and T. Fujita6,17, and J. L. Cole30, respectively. It represents a sensitive method to evaluate sensitivity alterations to trypsin treatment caused by conformational changes. Applying trypsin digestion, we detected rapid degradation of RIG-I and PKR in mock infected samples, whereas trypsin treatment of virus-infected cell lysates led to trypsin resistant RIG-I fragments. Similarly, a trypsin resistant PKR fragment was detected upon Cl 13 infection. This was accompanied by PKR phosphorylation at Thr 446, a widely used marker of PKR activation. Comparing trypsin digestion of mock and Cl 13 cell lysates by Coomassie staining demonstrates a comparable decrease of global protein levels. This indicates that formation of resistant fragments is specific for proteins like RIG-I and PKR.
The formation of oligomeric complexes of RIG-I, PKR and IRF-3 was monitored by native PAGE. Subjecting Cl 13-infected cell lysates to native PAGE, we detected RIG-I, PKR and IRF-3 oligomers, whereas these proteins remained as monomers in mock infected samples. RIG-I needs to form oligomers to activate downstream pathways. It was hypothesized that RIG-I oligomerization supports recruitment of cofactors to form a signaling platform for antiviral response mechanisms11. The function of PKR dimerization is not entirely understood. Most likely, the PKR subunits in the dimer phosphorylate each other25. The type I IFN system is tightly regulated on a transcriptional level, and IRF-3 represents one central transcription factor for the induction of IFN and ISGs38. Central hallmarks of activation are phosphorylation, dimerization, and translocation to the nucleus, where it recruits the transcriptional co-activators p300 and CREB-binding protein (CBP) to initiate IFN mRNA synthesis21,39. Analysis of IRF-3 dimerization is a widely used tool to monitor activation of the type I IFN response38. Therefore, we used the detection of IRF-3 oligomeric complexes as a proof of principle for the oligomerization assays of RIG-I and PKR oligomerization. Indeed, allowing separation of protein lysates under non-denaturing conditions, we were able to detect IRF-3 dimerization in Cl 13 infected samples.
Undoubtedly, each lab will need to optimize the protocols of limited protease digestion and native PAGE. If confronted with no detection of any resistant proteins or too many resistant fragments, one might shorten or prolong the time of digestion, respectively. Differences can also be due to the specific TPCK-trypsin stock, as preparations slightly differ. Therefore, various TPCK-trypsin concentrations should be tested for optimization. Cell lysates can be prepared from other cell lines than A549, but adaptations of the protocol might be required. It is recommended to adjust the amount of total proteins for trypsin digestion and native PAGE according to the expression level of the protein of interest in this specific cell type. Moreover, limited detection or weak separation of oligomeric complexes by native PAGE can have several reasons and can be addressed as followed: make sure that the equipment is cleaned to remove remaining denaturing agents, keep all samples and the gel during the PAGE at 4 °C, and do not extend the time between sample preparation and loading onto the gel. Limited protease digestion and native PAGE have also been employed to monitor the activation of another important, closely related PRR, MDA540-42. Monitoring of MDA5 activation required different experimental conditions compared to RIG-I and PKR, and was therefore not included here.
In summary, point-by-point protocols for two useful and sensitive methods to measure activation of RIG-I and PKR are presented. Limited protease digestion and native PAGE, both coupled to Western blot analysis, permit monitoring of conformational changes and oligomerization, respectively. Using these methods, we had previously shown that RIG-I can be activated by nucleocapsids of various viruses directly after their entry into the cells32.
The exact nature and origin of the RNA species relevant for RIG-I and PKR activation in infected cells are still not entirely solved. Furthermore, many viruses interfere with the functions of PRRs by a wide variety of strategies12,43-46. The presented techniques enlarge the spectrum of methods by allowing an easy and direct measurement of RIG-I and PKR activation, are quick to perform, and do not require expensive equipment.
The authors have nothing to disclose.
We thank Alejandro Brun from CISA-INIA for providing anti-Rift Valley fever Virus sera. Work in our laboratories is supported by Forschungsförderung gem. §2 Abs. 3 Kooperationsvertrag Universitätsklinikum Giessen und Marburg, the Leibniz Graduate School for Emerging viral diseases (EIDIS), the DFG Sonderforschungsbereich (SFB) 1021, and the DFG Schwerpunktprogramm (SPP) 1596.
Name | Company | Catalog Number | Yorumlar |
cell culture | |||
Dulbecco’s modified Eagle’s medium (DMEM) | Gibco | 21969-035 | |
OptiMEM | Gibco | 31985-47 | |
L-glutamine | PAA | 25030-024 | |
penicillin-streptomycin | PAA | 15070-063 | |
fetal calf serum (FCS) | PAA | 10270 | |
0.05% trypsin-EDTA | Gibco | 25300-054 | |
chemicals | |||
L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated (TPCK) trypsin | Sigma Aldrich | T1426 | |
antibodies | |||
mouse monoclonal anti-RIG-I antibody (ALME-1) | Enzo Life Sciences | ALX-804-849-C100 | WB: 1:500 in 1% skim milk in TBS |
mouse monoclonal anti-PKR (B10) | Santa Cruz | sc-6282 | WB: 1:500 in 1% skim milk in TBS |
rabbit monoclonal anti-P-PKR (Thr446) | Epitomics | 1120-1 | WB: 1:1.000 in 5% BSA in TBS |
rabbit polyclonal anti-IRF-3 | Santa Cruz | sc-9082 | WB: 1:500 in 1% skim milk in TBS |
rabbit monoclonal anti-P-IRF-3 (Ser386) | IBL | og-413 | WB: 1:100 in 1% skim milk in TBS |
rabbit anti-RVFV hyperimmune serum "C2" (MP-12) | Kindly provided by Alejandro Brun (CISA-INIA) | ||
WB: 1:2.000 in 1% skim milk in TBS | |||
mouse monoclonal anti-beta-actin (8H10D10) | Cell Signalling | 3700 | WB: 1:1.000 in 1% skim milk in TBS |
polyclonal peroxidase-conjugated goat anti-rabbit | Thermo Fisher | 0031460 1892914 | WB: 1:20.000 in 1% skim milk in TBS |
polyclonal peroxidase-conjugated goat anti-mouse | Thermo Fisher | 0031430 1892913 | WB: 1:20.000 in 1% skim milk in TBS |